Bio

Driscoll Ugarte serves as a team lead of the firm's Life Sciences and Medical Technologies industry group. He practices in the area of corporate law, including private equity financings, emerging companies, mergers and acquisitions and securities. Mr. Ugarte counsels public, domestic and foreign corporations through all stages of development, from formation and operation to capital-raising and exit, including public and private offerings of equity and debt, tender offers, proxy contests, going-private transactions and recapitalizations. He is a member of the firm's governing Partners Board. An increasing focus of Mr. Ugarte’s practice is advising single family offices on organization, tax-efficient structure and strategy with regard to direct investments and other acquisitions. He also advises start-up companies and entrepreneurs, venture capital investors and underwriters. Mr. Ugarte regularly counsels businesses in the industries of life sciences, biotech, medical devices, pharmaceutical and biologics; real estate; agribusiness; and aerospace. In addition to advising domestic business, he guides multinational and foreign companies in Asia, North America, Europe and Latin America on cross-border direct foreign investment and mergers and acquisitions activities. Mr. Ugarte is a 2002 graduate of Georgetown University Law Center and a cum laude graduate of the University of Florida. Prior to entering private practice, Mr. Ugarte served as a law clerk in the U.S. Court of Appeals for the Fifth District.